Borrowing from successful HIV/AIDS prophylaxis, a TrialSiteNews podcast suggests rethinking the use of a controversial FDA-approved medication to avoid severe COVID-19 disease. Read More
Let's stay in touch. Subscribe to our blog and get our best content in your inbox.